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Abstract
 
The propensity of naive CD4 T cells to become T helper (Th) type 2 cells correlates with sus-
ceptibility to infection by the protozoal parasite 
 
Leishmania major
 
. Using genetic linkage analysis,
we earlier identified 
 
Dice1
 
 as a Th2 cell bias-controlling quantitative trait locus on chromosome
16. Using interval-specific congenic mapping, we now resolve 
 
Dice1
 
 into two independent genetic
loci, 
 
Dice1.1
 
 and 
 
Dice1.2
 
, which control 
 
Il4
 
 expression from naive Th cells and thereby indi-
rectly control Th2 cell bias. Interestingly, only one of the two congenic intervals containing
 
Dice1.1
 
 and 
 
Dice1.2
 
, respectively, also contained an 
 
L. major
 
 response locus, indicating that 
 
L.
major
 
 responsiveness can be insensitive to determinants that influence Th2 cell bias by controlling
naive T cell 
 
Il4
 
 expression. These results lay the groundwork for identifying the 
 
Dice1.1
 
 and
 
Dice1.2
 
 genes controlling naive T cell 
 
Il4
 
 expression and 
 
L. major
 
 responses, and for testing
whether these control other Th2 cell–dependent processes such as worm expulsion, allergic
asthma, and dermatitis.
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Introduction
 
Mature Th cells have been classified into two main lineages
based upon their cytokine gene expression pattern: Th2,
which is permissive for IL-4 and IL-13 but not IFN-
 
 
 
,
 
 
 
and
Th1 with the reciprocal pattern. Th1 cells are essential for
the control of intracellular pathogens such as 
 
Leishmania
major
 
 (1), whereas Th2 cells play a key role in the control
of large extracellular pathogens such as helminths (2).
When inappropriately generated, Th2 cells can cause allergic
diseases such as asthma (3) or impede protection from 
 
L.
major
 
 and other intracellular pathogens (1).
IL-4, the signature cytokine of Th2 cells, is itself a criti-
cal determinant of Th2 cell development (4). On naive
CD4 T cells (the common progenitor of Th1 and Th2
cells), IL-4 engages the IL-4R to activate STAT6 that
in turn up-regulates the zinc finger transcription factor
GATA3, a master regulator of Th2 cell development (5, 6).
The initial in vivo source of the IL-4 necessary to instruct
Th2 cell development has been controversial, with reports
of contributions from mast cells, basophils, eosinophils, and
NK T cells (7, 8). Although it is difficult to exclude that in
specific contexts each of these cell types may play instruc-
tive roles for Th2 cell development, it is clear that in the
absence of inflammatory stimuli such as IL-12 and IFN-
 
 
 
,
naive Th cells can suffice to instruct their own Th2 cell de-
velopment by an autocrine IL-4 pathway (9–11). The initial
production of IL-4 in this pathway occurs even in the pres-
ence of blocking anti–IL-4R antibody or from STAT6 KO
naive Th cells. Despite its critical role in the initiation of
Th2 cell development, the TCR-dependent, IL-4R/STAT6-
independent pathway regulating the production of IL-4
from naive Th cells is not well understood.
The ability of naive Th cells to express IL-4 rapidly
(hereafter, nIL-4) and Th2 cell bias are linked phenotypic
traits subject to a wide degree of genetic variation. Among
common inbred mouse strains, these traits range from the
high nIL-4/high Th2 cell bias phenotypes of BALB/c to
the low nIL-4/low Th2 cell bias phenotypes of C57BL/6
and B10.D2 (9–11). Susceptibility to 
 
L. major
 
 infection
correlates with the high nIL-4/high Th2 cell bias pheno-
types of BALB/c, consistent with the known antagonistic
role of Th2 cell responses in the IFN-
 
 
 
–dependent activa-
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tion of macrophages required by the host to control intrac-
ellular parasite replication (12, 13).
To gain a better understanding of the genetic determi-
nants controlling susceptibility to Th2 cell–dependent dis-
eases, we earlier performed linkage analysis on a [(BALB/c 
 
 
 
C57BL/6)F1 
 
  
 
C57BL/6] backcross cohort to identify loci
regulating Th2 cell bias (9). 63 mice were genotyped for
the segregation of simple sequence length polymorphism
(SSLP) markers distributed across the genome at an average
density of 10 cM. These data were correlated with pheno-
typic measurements of Th2 cell bias by determining the
quantitative level of IL-4 secreted into the media of CD4-
enriched splenocyte cultures activated by TCR ligation. In
this culture system, parental BALB/c cells secrete 
 
 
 
50-fold
more IL-4 than C57BL/6 or B10.D2, and F1 animals dis-
play an intermediate phenotype, demonstrating codominant
inheritance of this trait (9). The phenotype distribution pro-
file of the backcross cohort indicated that Th2 cell bias was a
multigenic trait (9). A quantitative trait locus (QTL) desig-
nated 
 
Dice1
 
, accounting for 27% of the trait variance, was
detected on centromeric chromosome 16 (9).
Here, we describe the use of interval-specific congenic
mapping to identify the Th2 cell bias-controlling locus pre-
dicted by the 
 
Dice1
 
 QTL. Instead of one, we discovered
two loci, 
 
Dice1.1
 
 and 
 
Dice1.2
 
, which control Th2 cell bias.
In each case, the proximal target of this genetic control is
likely to be in the nIL-4 pathway, as both loci also control
nIL-4 levels. Despite sharing in common the ability to con-
trol nIL-4 and Th2 cell bias, we found that only one locus
(
 
Dice1.2
 
) could control susceptibility to 
 
L. major
 
 infection.
We discuss the implications of these findings for the role of
Th2 cell bias in determining 
 
L. major
 
 susceptibility.
 
Materials and Methods
 
Mice.
 
All mice were bred and maintained in specific patho-
gen-free or modified specific pathogen-free (for 
 
L. major
 
 infec-
tions) vivaria in the Health Sciences Complex at the University
of Washington according to protocols approved by the Univer-
sity of Washington Animal Care and Use Committee. BALB/
cAnN mice were obtained from Taconic Farms and B10.D2/
OsnJ mice were obtained from The Jackson Laboratory. BALB.
D2c16 was obtained at the eighth backcross to BALB/cAnN
(provided by A. Beebe and B. Coffman, DNAX Research Insti-
tute, Palo Alto, CA). Before the generation of the C.16D2 con-
genic panel, BALB.D2c16 was maintained through at least two
more rounds of serial backcrossing to BALB/cAnN coupled with
genotypic selection at each generation for retention of B10.D2
chromosome 16.
 
Producing Recombinant Congenic Strains.
 
BALB.D2c16 was
backcrossed to BALB/cAnN and progeny were screened for re-
combination across the congenic interval using SSLP markers
spanning chromosome 16 (see Online Supplemental Material
section below for marker information). Nine animals were se-
lected that together harbored a set of recombinant congenic in-
tervals (1–9) comprising a tiling path across most of chromosome
16. Each of these was then backcrossed to BALB/cAnN. Nonre-
combinant progeny from each backcross were identified by SSLP
screening and intercrossed to produce homozygous recombinant
congenic animals. These were identified by SSLP screening and
then intercrossed to generate a pure-breeding stock that had been
backcrossed to BALB/cAnN at least 11 times. The nine congenic
lines are designated C.16D2/1, C.16D2/2, C.16D2/3, C.16D2/4,
C.16D2/5, C.16D2/6, C.16D2/7, C.16D2/8, and C.16D2/9.
 
Th2 Cell Bias Assay.
 
CD4-enriched splenocytes were pre-
pared by complement-mediated lysis of CD8
 
  
 
T cells (3.155;
American Type Culture Collection [ATCC]]), MHC class II
 
  
 
B
cells, dendritic cells, and macrophages (BP107; ATCC), and HSA
 
 
 
B cells, 
 
  
 
  
 
T cells, monocytes, granulocytes, and erythrocytes
(J11d; ATCC). CD4 T cell purity, as determined by FACS analy-
sis, was always 
 
 
 
80%. In brief, total splenocytes (30 
 
  
 
10
 
6
 
/ml)
were incubated at 37
 
 
 
C in a cocktail of purified antibodies and a
combination of rabbit and guinea pig complement for 50 min. Live
cells were recovered by centrifugation through Ficoll, washed, re-
suspended in cell culture medium (RPMI 1640 with 10% heat-
inactivated fetal calf serum, 50 
 
 
 
M 
 
 
 
-mercaptoethanol, 2 mM
 
l
 
-glutamine, and 100 U/ml penicillin and streptomycin), counted,
and distributed (10
 
6 
 
CD4 T cell equivalents/well, determined by
FACS analysis) with 25 U/ml recombinant human IL-2 (Roche)
into 24-well plates precoated with 1 ug/ml anti-TCR
 
 
 
–specific
antibody (H57.597; ATCC). On day 5, cells were harvested, washed
extensively, counted, and redistributed (10
 
5
 
/well) with 25 U/ml
recombinant human IL-2 (Roche) into 96-well, flat-bottom plates
precoated with 10 ug/ml anti-TCR
 
 
 
–specific antibody (H57.597;
ATCC). 2 d later, supernatants were harvested and IL-4 content
was determined by ELISA (coating antibody, 11B11 [NIH Re-
sponse modifier program]; detecting antibody, BVD6 [ATCC]).
 
nIL-4 Assay.
 
Total RNA was isolated (STAT60; Tel-Test)
from CD4-enriched splenocytes (prepared and cultured as de-
scribed above) after 16 h of stimulation. RNA was converted to
cDNA with reverse transcriptase (Superscript II; Invitrogen) ac-
cording to the manufacturer’s instructions. 
 
Il4
 
 and 
 
Hprt
 
 sequence
content was then measured by quantitative real-time PCR using
intron-spanning primers (
 
Il4
 
: 5
 
 
 
-CTTATCGATGAATCCAG-
GCATCG-3
 
  
 
and 5
 
 
 
-CATCGGCATTTTGAACGAGGTCA-
3
 
 
 
; 
 
Hprt
 
: 5
 
 
 
-GAGGGTAGGCTGGCCTATAGGCT-3
 
 
 
 and 5
 
 
 
-
GTTGGATACAGGCCAGACTTTGTTG-3
 
 
 
). 
 
Il4
 
 expression
was normalized internally to 
 
Hprt
 
. These normalized values were
then expressed relative to expression in NIH3T3 fibroblasts (ATCC)
that do not express 
 
Il4
 
 (unpublished data).
 
L. major Infection.
 
Cohorts of anesthetized mice were inocu-
lated in both hind footpads with 
 
 
 
4 
 
  
 
10
 
5 
 
metacyclic promasti-
gotes of 
 
L. major
 
 (strain WHOM/IR/-/173), maintained as
described previously (14). The size of footpad lesions was
monitored weekly using metric calipers. Footpad thickness mea-
surements are presented as the value measured on a given day (the
group mean of six replicate measurements: three/foot/animal)
minus the value measured just before infection. 5–6 wk after in-
fection, animals were killed and footpad parasite burdens were
determined. Footpads were washed in ethanol and rinsed and ho-
mogenized in 10 ml M199 media using a Tissu-Tearor (model
398; Biospec Products). Homogenates were serially diluted into
96-well microtiter plates and incubated in the dark at room tem-
perature for 1 wk. Wells were monitored daily for motile pro-
mastigotes using inverted microscopy.
 
Statistical Analysis.
 
To compare results from different strains
and from different experiments conducted over a period of time,
we converted raw measurements into Index values (I
 
test
 
) that nor-
malized each mouse to the BALB/c and B10.D2 controls in a
given experiment. This was computed as follows: I
 
test 
 
  
 
(test 
 
 
 
mean
 
B10.D2
 
)/(mean
 
BALB/c 
 
  
 
mean
 
B10.D2
 
). In this way, I
 
test 
 
values
approaching 1 correspond to a BALB/c-like phenotype and those
approaching 0 indicate a B10.D2-like phenotype. Before per- 
Baguet et al.
 
1607
 
forming individual comparison tests of statistical significance, the
statistical significance of each entire dataset was first assessed using
the nonparametric Kruskal-Wallis test (nIL-4: P 
 
  
 
0.0001; Th2
cell bias: P 
 
  
 
0.0001). Multiple comparisons between control
BALB/c and each C.16D2 congenic strain were then assessed us-
ing the nonparametric Mann Whitney test. Results of this analy-
sis are shown in the legend to Fig. 3.
 
Online Supplemental Material
 
Table S1 shows SSLP markers
used to map chromosome 16. Shown are their names, positions
on chromosome 16 (NCBI Mapviewer, build 33.1), forward and
reverse primer sequences, and respective BALB/c and B10.D2
amplicon sizes (in basepairs). D16MIT markers are from MIT/
Whitehead, whereas DA1.5, D1.3, D8.3, and D10.2 were gener-
ated by us. Table S1 is available at http://www.jem.org/cgi/
content/full/jem.20040334/DC1.
 
Results
 
Producing the C.16D2 Congenic Panel.
 
We adopted the
classical strategy of Snell and Bunker (15) and constructed
a panel of nine inbred BALB/c strains coisogenic with
B10.D2 across discrete regions of chromosome 16, desig-
nated C.16D2/1-9. The C.16D2 congenic panel originated
from BALB.D2c16, an animal that was produced from a
founding (BALB/c 
 
  
 
B10.D2)F1 backcrossed eight times
to BALB/c and selected at each generation on the basis of
resistance to 
 
L. major
 
 (16). It contained a B10.D2-derived
congenic interval spanning the majority of chromosome 16.
We propagated this strain by further backcrossing to BALB/c
until at least N10, selecting progeny at each generation that
continued to retain most of B10.D2 chromosome 16. Sub-
sequently, recombinant progeny that had segregated only
fragments of B10.D2 chromosome 16 were selected and in-
dependently backcrossed to BALB/c. Sister/brother prog-
eny segregating the same recombinant intervals were then
intercrossed to generate strains harboring homozygous con-
genic intervals. Collectively, these congenic strains represent
an overlapping tiling path of B10.D2-derived genomic in-
tervals that spans 92% of chromosome 16 (Fig. 1).
 
Th2 Cell Bias Phenotype of C.16D2 Congenic Strains.
 
To phenotypically screen the congenic panel for the Th2
cell bias trait we used a T cell restimulation assay similar to
that used originally to identify the 
 
Dice1
 
 QTL (9). In brief,
this consisted of culturing CD4 T cell–enriched splenocytes
with plate-bound anti-TCR antibody and IL-2 for 5 d, fol-
lowed by recovery, washing, and restimulation at equiva-
lent cell number with anti-TCR antibody and IL-2. 2 d
later, IL-4 content in the media was measured by ELISA.
To identify B10.D2-derived congenic intervals that shifted
the phenotype of each BALB/c background congenic ani-
mal from BALB/c-like to B10.D2-like, we chose to com-
pare the phenotypes of each congenic strain with the
BALB/c parental strain. To compare results from multiple
experiments performed over a period of time, we con-
verted raw ELISA data (Fig. 2 A) into a Th2 cell bias index
value that normalized IL-4 expression to the levels exhib-
ited by the BALB/c and B10.D2 controls in a given exper-
iment. Five of the nine C.16D2 congenic strains (C.16D2/
3, 4, 5, 7, and 8) displayed significantly reduced Th2 cell
bias compared with the high Th2 cell bias of the BALB/c
control (Fig. 2 A and Fig. 3, top). By comparing the physi-
cal location of the chromosome 16 congenic intervals con-
tained in the 
 
Dice
 
  
 
and 
 
Dice
 
  
 
C.16D2 strains we inferred
the existence of at least two distinct loci controlling Th2
cell bias that we designated 
 
Dice1.1
 
 and 
 
Dice1.2
 
 (Fig. 1).
The minimal 
 
Dice1.1
 
 and 
 
Dice1.2
 
 intervals are respectively,
3.2Mb (D16MIT142-D16MIT164) and 27.6Mb (D16MIT138-
D16MIT27). Thus, by interval-specific congenic mapping
we have revealed the 
 
Dice1
 
 QTL to be genetically com-
plex, comprising at least two independent loci, one of
which (
 
Dice1.1
 
) is within the original 95% confidence in-
terval for the location of 
 
Dice1
 
. With these loci isolated in
separate inbred strains segregating nonoverlapping con-
genic intervals, it was possible to test for the independent
effects of each locus on other phenotypes.
 
nIL-4 Phenotype of C.16D2 Congenic Strains.
 
In inde-
pendent [(BALB/c 
 
  
 
C57BL/6) 
 
  
 
C57BL/6] backcross co-
horts we noted similar phenotype distributions for the nIL-4
and the Th2 cell bias phenotypes (9). To test whether a com-
Figure 1. Physical location of C.16D2 congenic intervals on chromo-
some 16. Shown for each C.16D2 strain (labeled at the top) are the por-
tions of chromosome 16 inherited from B10.D2 (shaded) and BALB/c
(unshaded). Locations where genotypes were determined are indicated
with black diamonds. Genotyping markers used and their locations along
chromosome 16 are indicated on the right axis. Double-headed arrows
and horizontal lines indicate the inferred locations for Dice1.1 (closed arrow-
heads) and Dice1.2 (open arrowheads). 
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mon genetic pathway controlled both traits, we phenotyped
the C.16D2 congenic strains for the nIL-4 trait by quantita-
tive real-time RT-PCR measurement of Il4 mRNA abun-
dance in 16-h stimulated, CD4 T cell–enriched splenocytes
(Fig. 2 B). Five congenic strains (C.16D2/3, 4, 5, 7, and 8)
displayed significant differences with the BALB/c control
(Fig. 2 B and Fig. 3, bottom). Concordance in the pheno-
types reported by the 16-h nIL-4 mRNA assay and the 7-d
Th2 cell bias protein assay suggests that Dice1.1 and Dice1.2
control both traits. These results support the hypothesis that
autocrine IL-4 production by naive CD4 T cells is a critical
Th2 cell determinant and that Dice1.1 and Dice1.2 each act
in a polymorphic pathway(s) leading to its production.
L. major Susceptibility of C.16D2 Congenic Strains.
Given the known role that Th2 cell bias plays in the suscep-
tibility of the BALB/c strain to infection by the protozoal
parasite L. major (1), we hypothesized that the Dice1.1  and
Dice1.2  C16.D2 strains would display reduced susceptibil-
ity compared with BALB/c. To test this, we injected para-
sites into the footpads of control and congenic mice and fol-
lowed the infection course by measuring footpad thickness
at weekly intervals and footpad parasite burdens at the end
of the assay. Contrary to our expectation, the Dice1.1 
C.16D2/3 and C.16D2/5 strains shared an infection course
with the susceptible Dice1.1  C.16D2/6 strain and the
BALB/c control (Fig. 4, A and C). By contrast, the
Dice1.2  C.16D2/8 strain exhibited an infection course
shifted toward the resistant phenotype of the B10.D2 con-
trol (Fig. 4 C). The susceptible and resistant phenotypes of
mice harboring Dice1.1 and Dice1.2 congenic intervals, re-
spectively, was also reflected in footpad parasite burdens
(Fig. 4, B and D). Thus, the Dice1.2 but not the Dice1.1
congenic interval contains an L. major response locus.
Discussion
Interval-specific Congenic Mapping. Although human ge-
netic studies have succeeded in identifying many disease-
Figure 2. Representative raw Th2 cell bias and
nIL-4 data. CD4-enriched splenocyte cultures stimulated
with plate-bound anti-TCR and IL-2 were harvested
(A) at 5 d for cells or (B) at 16 h for RNA. Cells har-
vested at 5 d were washed, counted, and restimulated at
equivalent cell numbers for an additional 2 d, followed by
analysis of IL-4 content in the media by ELISA. RNA
analysis was by real-time RT-PCR with data normal-
ized to HPRT and expressed relative to expression in
NIH3T3 fibroblasts. Red, black, and open bars repre-
sent BALB/c, B10.D2, and C.16D2 strain mice (1–9),
respectively. Where bars are not visible, value was below
the limit of detection.Baguet et al. 1609
linked QTL, rarely have these lead to the identification of
susceptibility genes, and the majority languish in an uncon-
firmed state (17, 18). Most likely, this failure is due to the
genetic complexity of disease susceptibility, involving mul-
tiple epistatic gene–gene and gene–environment effects
that confound analysis. By modeling complex human dis-
eases in mice, it becomes possible to take a reductionist
approach to genetic dissection whereby individual suscep-
tibility genes can be isolated on uniform genetic back-
grounds and phenotypically analyzed in strictly controlled
environments.
To confirm and genetically resolve the Dice1 QTL con-
trolling Th2 cell bias, a trait associated with susceptibility to
allergic airway disease and L. major infection, we undertook
the classical interval-specific congenic mapping approach of
Snell and Bunker (15). This approach converts a complex
multigenic trait into its component genes, each isolated on
distinct congenic intervals, segregating in separate inbred
strains that, once produced, are good substrates for straight-
forward positional, expression, and/or candidate gene clon-
ing strategies. The main pitfall of the approach is that
phenotypic expression of a targeted QTL, once isolated
from other genes contributing to the measured trait, may
no longer be sufficiently strong and penetrant to allow reli-
able detection. Second, even if scorable phenotypes are
maintained, there is no guarantee that a particular QTL will
contain only a single gene. Indeed, it is not uncommon (as
was the case in this study) for QTL to resolve into multiple
distinct loci (17). In this case, further genetic resolution will
depend upon each component gene’s ability to confer con-
tinued phenotypic detection. Fortunately, this dilution ef-
fect can be offset partially in the case of recessive and
codominantly inherited traits by interrogating congenic in-
tervals in their homozygous state. Despite its potential
shortcomings, interval-specific congenic mapping is prov-
ing to be a powerful tool for the identification of compo-
nent genes involved in complex multigenic traits. Prom-
inent recent examples include susceptibility to allergic
airway disease (asthma) and autoimmune disease (systemic
lupus erythematosus; references 12 and 19). This study adds
Dice1 to the growing list of QTL that have yielded to inter-
val-specific congenic mapping, an example, in this case, of
a locus controlling susceptibility in an experimental model
of a human infectious disease, cutaneous leishmaniasis.
The Th2 cell bias phenotypes conferred by Dice1.1 and
Dice1.2 were both incompletely penetrant, requiring the
analysis of multiple mice for their reliable detection. This
result is consistent with the expectation that each compo-
nent gene involved in a multigenic trait will contribute
only a portion of the overall phenotype. It will be interest-
ing to compare the phenotypes of bicongenic mice harbor-
ing both Dice1.1 and Dice1.2 with either monocongenic.
An additive/non-epistatic phenotype would suggest that
Dice1.1 and Dice1.2 participate in parallel pathways, whereas
Figure 3. Concordance between Th2 cell bias and nIL-4 traits among C.16D2 congenic strains. Shown are scatter plots of Th2 cell bias (top) and nIL-4
index values (bottom) of individual BALB/c (open circles) and C.16D2 congenic animals (gray triangles). Data shown are from experiments in which
control BALB/c and B10.D2 differed significantly. For Th2 cell bias experiments involving C16.D2 strains 1–5, 7, and 8, P   0.09; for C16.D2 strains 6
and 9, P   0.2; and for all nIL-4 experiments, P   0.1. C16.D2 strains with phenotypes significantly lower than control BALB/c are indicated with an
asterisk. Multiple comparison tests of significance were performed using the Mann-Whitney nonparametric test. P-values (Th2 cell bias, nIL-4) are as follows:
C16D2/1 (0.5000, 0.500), C16D2/2 (0.7357, 0.8689), C16D2/3 ( 0.0001,  0.0001), C16D2/4 (0.0002, 0.0008), C16D2/5 (0.0018,  0.0001),
C16D2/6 (0.7884, 0.5000), C16D2/7 (0.0163, 0.003), C16D2/8 (0.0286, 0.0271), and C16D2/9 (0.1304, 0.5000).Th2 Cell Bias and Leishmania Resistance 1610
a synergistic or epistatic phenotype would suggest partici-
pation in a linear pathway. Given that the original Dice1
QTL could only account for 27% of the variance in Th2
cell bias between BALB/c and C57BL/6 in our original
backcross cohort, it is perhaps surprising that the pheno-
types controlled by Dice1.1 and Dice1.2 are so robust. Most
likely, this reflects the advantage of scoring a codominant
trait within animals harboring homozygous congenic
B10.D2 intervals on a genetically homogeneous BALB/c
background in the absence of confounding epistatic “noise”
present in the original backcross cohort, resulting from
the random segregation of multiple interacting B10.D2
intervals.
Identifying Genes Involved in Th2 Cell–dependent Diseases
by Screening Genetic Loci Involved in Th2 Cell Bias. Suscep-
tibility to many immunological diseases arises from variation
in the type of Th cell response elicited by foreign agents. In
particular, susceptibility to allergic airway disease and cuta-
neous leishmaniasis is associated with inappropriate Th2
cell–biased responses (1, 12, 13). We hypothesized that dis-
ease susceptibility genes could be identified by focusing on
simpler cellular (as opposed to organismal) traits that control
key disease susceptibility pathways. Thus, we set out to
identify genes involved in controlling Th2 cell bias with the
hope that these would lead to the identification of genes in-
volved in Th2 cell–dependent diseases. Providing validation
for this approach, a recent study of asthma susceptibility ex-
ploited the HBA congenic strain, produced on a BALB/c
background with a chromosome 11 genomic interval inher-
ited from DBA/2. Although the congenic interval in this
strain was selected on the basis of its ability to regulate Th2
cell bias, subsequent positional cloning uncovered the con-
trolling Tim gene family as having a role in asthma suscepti-
bility (20). Similarly, our interval-specific congenic mapping
of the Th2 cell bias regulatory Dice1 QTL led to identifica-
tion of a novel response locus for L. major. Together, these
two examples support the general strategy of identifying
genes involved in genetically complex Th2 cell–dependent
susceptibility phenotypes by screening loci involved in con-
trolling a simpler cellular phenotype: Th2 cell bias. It re-
mains to be seen whether the Tim gene family plays a role in
L. major susceptibility or if Dice1.1 and Dice1.2 play a role in
asthma susceptibility.
Candidate Genes. The minimal Dice1.1 congenic inter-
val spans 3.2 Mb, contains 35 genes (NCBI Mapviewer,
build 33.1), and overlaps the 95% confidence interval for
the location of the original Dice1 QTL (2.5 cM centered
on D16MIT81; reference 9). Potential candidate genes in
this interval include those encoding transcription factors
CRHSP-24 and CIITA and the intracellular signaling pro-
tein SOCS1 (21–23). Of these, the transcription factor CI-
ITA is perhaps the most interesting insofar as it has been
shown to interfere directly with Il4 expression in vivo (22).
However, despite significantly lower expression of Il4 in
16-h stimulated splenocytes from C57BL/6 compared with
BALB/c, no difference was detected in the level of C2ta
mRNA (unpublished data). We cannot exclude the possi-
bilities that analysis of highly purified naive CD4 T cells
would reveal differential expression for C2ta or that a
structural polymorphism underlies Dice1.1. Comparative
sequencing and further differential expression analysis stud-
ies of C2ta and other Dice1.1 candidate genes are ongoing.
The minimal Dice1.2 congenic interval is large, spans
27.6 Mb, and includes 145 genes (NCBI Mapviewer, build
33.1). Potential candidate genes in this interval include
those encoding the HMG box transcription factor BBX,
the E3 ubiquitin ligase CBL-B, and the pituitary-specific
transcription factor PIT1 (24–26). Another Th2 cell bias-
controlling QTL called Cypr1 (cytokine production 1) has
been mapped to a region of chromosome 16 just centro-
meric of the Dice1.2 interval (27), suggesting the possible
Figure 4. Response to L. major infection of mice harboring Dice1.1
and Dice1.2 congenic intervals. Groups of five to six mice were infected
with metacyclic L. major parasites. The disease course was monitored by
weekly measurement of footpad lesion size (A and C) and, at termination,
footpad parasite burdens (B and D) in BALB/c (red fill), B10.D2 (black
fill), and C16.D2 (white fill) strain mice. Error bars show SEM. Similar
results for C.16D2/8 were obtained in three independent experiments.Baguet et al. 1611
identity of the locus predicted by Cypr1 and Dice1.2. The
founding mouse used to produce the C.16D2 panel arose
in the course of a study that used serial backcross mapping
to identify six L. major resistance QTL, one of which
mapped to the distal part of chromosome 16 (16). Trans-
mission/disequilibrium testing suggested that this QTL was
dependent upon epistatic interactions for its phenotypic ex-
pression, possibly explaining why its association with resis-
tance in that study fell short of statistical significance.
Nonetheless, one of the two chromosome 16 SSLP mark-
ers (D16MIT5) with the lowest p-values for association
with resistance in this earlier study occurs within the
Dice1.2 congenic interval, suggesting the possibility of
identity between the locus predicted by this QTL and the
L. major response locus we have identified.
The Functions of Dice1.1 and Dice1.2. The strength of
the nIL-4 and Th2 cell bias phenotypes (as reflected in the
magnitude of Mann-Whitney p-values) displayed excellent
concordance in all nine C16.D2 strains. The strength of
both phenotypes was uniformly higher for strains contain-
ing  Dice1.1 as opposed to Dice1.2. Together with the
known requirement for nIL-4 in the development of Th2
cell bias (9–11), this result strongly suggests that the pri-
mary targets of both Dice1.1 and Dice1.2 are in the nIL-4
pathway. Developmental acquisition of the Dice-controlled
nIL-4 trait has been shown to be T cell lineage autono-
mous (9), implying that Dice1.1 and Dice1.2 also act di-
rectly within naive T cells rather than indirectly through
some other interacting cell type. Previous studies have
shown that the Th2 cell bias trait is reflected in the propor-
tion of IL-4–expressing cells as opposed to the level of IL-4
expression per cell, indicating a stochastic element to the
Th2 cell commitment process (9). Together, our evidence
that Dice1.1 and Dice1.2 influence Th2 cell bias indirectly
through effects on nIL-4 imply that the level of IL-4 se-
creted by naive CD4 T cells contributes to their likelihood
of maintaining Il4 in a transcriptionally permissive state.
Biochemical and proteomic analysis of Th cells from the
C.16D2 congenic strains will allow elucidation of the sig-
naling pathways and components proximal to the Dice1.1
and Dice1.2 gene products, and may facilitate the identifi-
cation of the Dice1.1 and Dice1.2 genes.
The Role of Dice1.1 and Dice1.2 in L. major Resistance.
The decreased susceptibility of L. major–infected C.16D2/8
compared with control BALB/c indicates the existence of a
disease response locus within the Dice1.2 congenic interval.
Given the critical role of IL-4 regulation in L. major suscep-
tibility (1), and given that Dice1.2 controls nIL-4 and Th2
cell bias, it is tempting to speculate that the same locus in
the Dice1.2 congenic interval controls all three phenotypes.
However, given that the nIL-4 and Th2 cell bias pheno-
types of Dice1.1 are stronger than Dice1.2, how can we ex-
plain the inability of the Dice1.1 congenic strains to resist L.
major infection? One possibility is that the magnitudes of
the nIL-4 and Th2 cell bias phenotypes controlled by ei-
ther Dice1.1 or Dice1.2 are insufficient to confer L. major
resistance. Dice1.1 and Dice1.2 may act in parallel biochem-
ical pathways, each with independent as well as common
targets, L major susceptibility being a Dice1.2-specific target
and Il4 a shared target. Alternatively, L. major resistance
may require an additional gene cosegregating with Dice1.2.
In this case, it should be possible to separate an L. major re-
sponse locus (Lmr) from Dice1.2 itself. Such a locus would
be predicted to behave like the recently described Lmr loci
that use a Th1/Th2 cell–independent mechanism to con-
trol the differential responses to L. major of BALB/c and
C57BL/6 (28). However, if a resistance locus in the
Dice1.2 congenic interval operates in a Th1/Th2 cell–inde-
pendent  Lmr-like pathway, it would represent a novel
member of this group because the known Lmr loci are lo-
cated on chromosomes 9, 17, and X (28). Nevertheless, in
support of this possibility is the similar abundance of Il4
mRNA recovered from draining popliteal lymph nodes 6
wk after L. major infection of resistant C.16D2/8 and sus-
ceptible BALB/c mice (unpublished data).
In summary, the genetic locus predicted by the Th2 cell
bias–controlling Dice1 QTL is confirmed and resolved into
two independent loci, Dice1.1 and Dice1.2. The additional
ability of each locus to control Il4 expression from naive
CD4 T cells, a known determinant of Th2 cell bias, sug-
gests strongly that the proximal targets of both Dice1.1 and
Dice1.2 occur in the naive T cell IL-4 pathway. In addi-
tion,  Dice1.2 (or a tightly linked gene) controls the re-
sponse to L. major infection, a paradigm for Th2 cell–
dependent disease. The C.16D2 congenic panel will
provide an opportunity to molecularly dissect the naive T
cell IL-4 pathway and study the role of Th2 cell bias in the
development of other Th2 cell–dependent processes such
as worm expulsion, allergic asthma, and dermatitis.
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